Table 2. Frequency of CD4⁺ and CD8⁺CD45RC subsets according presence or absence of post-transplant complications.

Results are expressed as the % of subset among CD4⁺ or CD8⁺ T cells.

	Yes	No	p
Acute rejection, n	18	71
CD4 CD45RC high	55.3 ± 10.8	45.2 ± 15.7	0.012
CD8 CD45RC high	63.2 ± 9.8	45.0 ± 16.2	<0.001
CD8 CD45RC int	23.9 ± 8.1	33.6 ± 11.3	0.001
CD8 CD45RC low	12.9 ± 3.9	21.8 ± 11.3	0.001
Cancer, all types, n	25	64
CD4 CD45RC high	39.1 ± 13.9	50.4 ± 14.8	0.001
CD8 CD45RC high	41.7 ± 16.2	51.4 ± 13.3	0.014
CD8 CD45RC int	35.8 ± 13.8	30.0 ± 10.0	0.028
CD8 CD45RC low	22.4 ± 10.2	19.1 ± 11.1	0.189
Death, n	14	75
CD4 CD45RC high	37.2 ± 13.9	50.0 ± 14.6	0.001
CD8 CD45RC high	39.9 ± 15.4	51.1 ± 16.5	0.008
CD8 CD45RC int	35.8 ± 11.4	30.4 ± 11.2	0.064
CD8 CD45RC low	24.3 ± 12.5	18.9 ± 10.1	0.051